Reporter

Ann Richmond, PhD, is stepping down from her role as associate director for Research Education at Vanderbilt-Ingram Cancer Center.
July 16, 2020

Richmond steps down as associate director for Research Education for VICC

After serving 16 years as associate director for Research Education at Vanderbilt-Ingram Cancer Center (VICC), Ann Richmond, PhD, Ingram Professor of Cancer Research, is stepping down from the leadership post.

By Tom Wilemon
July 16, 2020

Brooks, Adams to lead VUMC advisory boards

Grammy Award-winning country music artist Kix Brooks is the new chair of Monroe Carell Jr. Children’s Hospital at Vanderbilt Advisory Board, taking over for outgoing chair Allison DeMarcus. Louise Adams, who succeeds Judge Les Smith, was recently named the chair of the Vanderbilt Eye Institute (VEI) Advisory Board.

By Nancy Humphrey
July 16, 2020

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.

By VUMC News and Communications
July 15, 2020

Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.

By Bill Snyder
July 15, 2020

Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

By Bill Snyder
Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
July 14, 2020

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.

By Leigh MacMillan
July 14, 2020

New tools to study bioactive lipids

Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.
By Leigh MacMillan
July 13, 2020

Human lungs rejected for transplant recovered using novel technique

A multidisciplinary team from Vanderbilt University Medical Center and Columbia University has demonstrated that injured human donor lungs declined for transplant can be recovered by cross-circulation between the human lung and a xenogeneic host.
By Matt Batcheldor
July 13, 2020

“Nur” target may aid arthritis treatment

Vanderbilt immunologists have discovered that the protein Nur77 is part of a control mechanism that guards against autoimmunity in natural killer T cells.
By Bill Snyder
July 10, 2020

VUMC team fills COVID information gaps for web users

For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.
By Paul Govern
July 9, 2020

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.
By VUMC News and Communications
July 9, 2020

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.
By Bill Snyder
July 9, 2020

Recurrent UTIs linked to hidden reservoir

Bacterial invasion of vaginal cells sets up a protective niche and a reservoir for recurrent urinary tract infections, Vanderbilt researchers demonstrated.
By Sarah E. Glass
1 … 182 183 184 185 186 … 725